OST submitted regulatory updates to the FDA and held a conference in Utah.
1 report, 0 independent
Updated Jun 30
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
OST submitted regulatory updates to the FDA and held a conference in Utah.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.
- FDA approval is the goal for product candidates from Daré Bioscience, Inc.
- FDA approval supports NDA submission in Aurora.
- Congress and the Senate are considering legislation affecting FDA submissions and drug patent rights.
- Litigation regarding FDA approval process.
Coverage
Newest first; wire copies grouped- Unknown outlet